NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Norepinephrine Bitartrate In 0.9% Sodium Chloride, and what generic alternatives are available?
Norepinephrine Bitartrate In 0.9% Sodium Chloride is a drug marketed by Inforlife and Long Grove Pharms and is included in two NDAs. There are seven patents protecting this drug.
This drug has three patent family members in two countries.
The generic ingredient in NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE is norepinephrine bitartrate. There are five drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the norepinephrine bitartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Norepinephrine Bitartrate In 0.9% Sodium Chloride
A generic version of NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE was approved as norepinephrine bitartrate by MEITHEAL on March 3rd, 2003.
Summary for NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE
International Patents: | 3 |
US Patents: | 7 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 2 |
Clinical Trials: | 8 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE at DailyMed |
Recent Clinical Trials for NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Tunis University | Phase 4 |
Second Affiliated Hospital, School of Medicine, Zhejiang University | N/A |
Wright State University | Phase 3 |
See all NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE clinical trials
Pharmacology for NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE
Drug Class | Catecholamine |
Anatomical Therapeutic Chemical (ATC) Classes for NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE
US Patents and Regulatory Information for NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE
NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE is protected by seven US patents.
Patents protecting NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE
Norepinephrine compositions and methods therefor
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Norepinephrine compositions and methods therefor
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: INDICATED TO RAISE BLOOD PRESSURE IN ADULT PATIENTS WITH SEVERE, ACUTE HYPOTENSION
Norepinephrine compositions and methods therefor
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: INDICATED TO RAISE BLOOD PRESSURE IN ADULT PATIENTS WITH SEVERE, ACUTE HYPOTENSION
Norepinephrine compositions and methods therefor
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Storage stable ready-to-use norepinephrine aqueous solutions in flexible plastic bags
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: INDICATED TO RAISE BLOOD PRESSURE IN ADULT PATIENTS WITH SEVERE, ACUTE HYPOTENSION
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Inforlife | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | norepinephrine bitartrate | SOLUTION;INTRAVENOUS | 215700-001 | Sep 15, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Long Grove Pharms | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | norepinephrine bitartrate | SOLUTION;INTRAVENOUS | 214628-003 | Oct 6, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Long Grove Pharms | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | norepinephrine bitartrate | SOLUTION;INTRAVENOUS | 214628-001 | Oct 6, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Long Grove Pharms | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | norepinephrine bitartrate | SOLUTION;INTRAVENOUS | 214628-001 | Oct 6, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Long Grove Pharms | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | norepinephrine bitartrate | SOLUTION;INTRAVENOUS | 214628-002 | Oct 6, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Long Grove Pharms | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | norepinephrine bitartrate | SOLUTION;INTRAVENOUS | 214628-003 | Oct 6, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE
See the table below for patents covering NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Canada | 3051467 | COMPOSITIONS DE NOREPINEPHRINE ET PROCEDES ASSOCIES (NOREPINEPHRINE COMPOSITIONS AND METHODS THEREFOR) | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2018140894 | ⤷ Try a Trial | |
World Intellectual Property Organization (WIPO) | 2020217079 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |